Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ORMP

Oramed Pharmaceuticals (ORMP)

Oramed Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ORMP
DateTimeSourceHeadlineSymbolCompany
16/10/202023:40PR Newswire (US)Oramed Issues Shareholder Update on Pivotal Phase 3 Oral Insulin Studies: Protocols Submitted to FDANASDAQ:ORMPOramed Pharmaceuticals Inc
21/09/202022:25PR Newswire (US)Oramed Pharmaceuticals to Present at the European Association for the Study of Diabetes (EASD) Annual MeetingNASDAQ:ORMPOramed Pharmaceuticals Inc
15/09/202022:25PR Newswire (US)Oramed's Diabetes Market Survey Shows Strong Support for ORMD-0801 Oral Insulin Among Physicians and PatientsNASDAQ:ORMPOramed Pharmaceuticals Inc
10/09/202006:14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
03/09/202022:10PR Newswire (US)Oramed to Present at H.C. Wainwright Global Investment ConferenceNASDAQ:ORMPOramed Pharmaceuticals Inc
28/08/202006:44Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
12/08/202006:40Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ORMPOramed Pharmaceuticals Inc
15/07/202023:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
15/07/202022:55PR Newswire (US)Oramed Reports Positive End of Phase 2 Meeting With the FDA for Oral InsulinNASDAQ:ORMPOramed Pharmaceuticals Inc
08/07/202006:14Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ORMPOramed Pharmaceuticals Inc
01/07/202006:10Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ORMPOramed Pharmaceuticals Inc
17/06/202006:28Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ORMPOramed Pharmaceuticals Inc
15/06/202022:25PR Newswire (US)Oramed Announces Positive Initial Clinical Trial Results for Treatment of NASH With Oral InsulinNASDAQ:ORMPOramed Pharmaceuticals Inc
05/05/202021:55PR Newswire (US)Oramed Pharmaceuticals to Present at the 80th American Diabetes Association Scientific Session, to be Held Virtually This Yea...NASDAQ:ORMPOramed Pharmaceuticals Inc
02/05/202001:17Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ORMPOramed Pharmaceuticals Inc
02/05/202001:15Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ORMPOramed Pharmaceuticals Inc
10/04/202006:43Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
07/04/202021:40PR Newswire (US)Oramed Patent in Canada Allowed for Oral Delivery of ProteinsNASDAQ:ORMPOramed Pharmaceuticals Inc
07/04/202006:47Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ORMPOramed Pharmaceuticals Inc
01/04/202023:40PR Newswire (US)Oramed Pharmaceuticals Issues CEO Shareholder Letter Providing Business Update Amid COVID-19NASDAQ:ORMPOramed Pharmaceuticals Inc
19/03/202023:40PR Newswire (US)Oramed Receives Positive Feedback From End-of-Phase 2 Oral Insulin CMC Meeting With FDANASDAQ:ORMPOramed Pharmaceuticals Inc
03/03/202003:45Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ORMPOramed Pharmaceuticals Inc
29/02/202005:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
28/02/202001:15PR Newswire (US)Oramed Pharmaceuticals Inc. Prices Public Offering of Common Stock for Aggregate Proceeds of $21 MillionNASDAQ:ORMPOramed Pharmaceuticals Inc
27/02/202008:14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ORMPOramed Pharmaceuticals Inc
27/02/202008:05PR Newswire (US)Oramed Pharmaceuticals Inc. Announces Proposed Public Offering of Common StockNASDAQ:ORMPOramed Pharmaceuticals Inc
27/02/202000:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
27/02/202000:00PR Newswire (US)Oramed Reports Positive Results in the Final Cohort of Its Phase 2b Oral Insulin TrialNASDAQ:ORMPOramed Pharmaceuticals Inc
15/02/202003:56Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ORMPOramed Pharmaceuticals Inc
12/02/202003:47Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ORMPOramed Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ORMP